Trulicity (Eli Lilly and Company)
Welcome to the PulseAid listing for the Trulicity drug offered from Eli Lilly and Company. This GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
NON-PROPRIETARY NAME: | Dulaglutide |
SUBSTANCE NAME: | DULAGLUTIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2014-11-07 |
END MARKETING DATE: | 0000-00-00 |
Trulicity HUMAN PRESCRIPTION DRUG Details:
Item Description | Trulicity from Eli Lilly and Company |
LABELER NAME: | Eli Lilly and Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.75(mg/.5mL) |
START MARKETING DATE: | 2014-11-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0002-1433_b39d3d3d-6b7c-40c2-becb-953830f47f3f |
PRODUCT NDC: | 0002-1433 |
APPLICATION NUMBER: | BLA125469 |
Other DULAGLUTIDE Pharmaceutical Manufacturers / Labelers: